• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SOCS6 下调:生存分析证实其为胃肠道间质瘤的不利预后因素。

Down-regulation of SOCS6: an unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis.

机构信息

Center of Digestive Diseases, The Seventh Affiliated Hospital, Sun Yat-sen University, Zhenyuan Road 628, Guangming District, Shenzhen, Guangdong, China.

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Zhongshan Road 58, Yuexiu District, Guangzhou, Guangdong, China.

出版信息

Diagn Pathol. 2021 Dec 12;16(1):113. doi: 10.1186/s13000-021-01172-6.

DOI:10.1186/s13000-021-01172-6
PMID:34895274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8667422/
Abstract

BACKGROUND

Many studies reporting that down-regulation of SOCS6 plays vital roles in promoting progression of malignant tumors have been published. The present study was performed to evaluate whether SOCS6 was significantly associated with prognosis of GIST patients.

METHODS

Immunohistochemical staining was accomplished to evaluate the expression levels of SOCS6 among GIST patients. The impacts of SOCS6 expression on overall survival (OS) and recurrence-free survival (RFS) of GIST patients were assessed by Cox proportional hazard regression model analysis and Kaplan-Meier curve analysis.

RESULTS

It was demonstrated that the expression level of SOCS6 was significantly associated with tumor size (P=0.001). Then according to Kaplan-Meier curve analysis, low expression of SOCS6 was significantly correlated with worse OS and RFS of GIST patients. Ultimately, it was revealed by Cox proportional regression model analysis that low expression of SOCS6 was an independent predictive factor for OS and RFS.

CONCLUSIONS

Low expression of SOCS6 was an independent prognostic factor for GIST, suggesting its potential as a novel biomarker predicting survival of GIST patients.

摘要

背景

许多研究报告表明,SOCS6 的下调在促进恶性肿瘤的进展中起着至关重要的作用。本研究旨在评估 SOCS6 是否与 GIST 患者的预后显著相关。

方法

采用免疫组织化学染色法评估 GIST 患者 SOCS6 的表达水平。通过 Cox 比例风险回归模型分析和 Kaplan-Meier 曲线分析评估 SOCS6 表达对 GIST 患者总生存(OS)和无复发生存(RFS)的影响。

结果

结果表明,SOCS6 的表达水平与肿瘤大小显著相关(P=0.001)。然后,根据 Kaplan-Meier 曲线分析,SOCS6 的低表达与 GIST 患者的 OS 和 RFS 较差显著相关。最终,通过 Cox 比例回归模型分析发现,SOCS6 的低表达是 OS 和 RFS 的独立预测因素。

结论

SOCS6 的低表达是 GIST 的独立预后因素,提示其可能成为预测 GIST 患者生存的新型生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c638/8667422/5c1e3b7e4346/13000_2021_1172_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c638/8667422/0f86c186a53c/13000_2021_1172_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c638/8667422/62e0dd0150ee/13000_2021_1172_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c638/8667422/42907cb486a0/13000_2021_1172_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c638/8667422/5c1e3b7e4346/13000_2021_1172_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c638/8667422/0f86c186a53c/13000_2021_1172_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c638/8667422/62e0dd0150ee/13000_2021_1172_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c638/8667422/42907cb486a0/13000_2021_1172_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c638/8667422/5c1e3b7e4346/13000_2021_1172_Fig4_HTML.jpg

相似文献

1
Down-regulation of SOCS6: an unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis.SOCS6 下调:生存分析证实其为胃肠道间质瘤的不利预后因素。
Diagn Pathol. 2021 Dec 12;16(1):113. doi: 10.1186/s13000-021-01172-6.
2
SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis.SLITRK3表达与胃肠道间质瘤风险分级及预后的相关性
World J Gastroenterol. 2015 Jul 21;21(27):8398-407. doi: 10.3748/wjg.v21.i27.8398.
3
Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.胃肠道间质瘤的预后血管生成标志物(内皮糖蛋白、血管内皮生长因子、CD31)和肿瘤细胞增殖(Ki67)
World J Gastroenterol. 2015 Jun 14;21(22):6924-30. doi: 10.3748/wjg.v21.i22.6924.
4
Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.Ki-67 在胃肠道间质瘤中的预后价值。
World J Gastroenterol. 2013 Jan 28;19(4):523-7. doi: 10.3748/wjg.v19.i4.523.
5
Clinico-pathological characteristics and prognostic factors of gastrointestinal stromal tumors among a Chinese population.中国人群胃肠道间质瘤的临床病理特征及预后因素
Int J Clin Exp Pathol. 2015 Dec 1;8(12):15969-76. eCollection 2015.
6
Physician Underestimation of the Risk of Gastrointestinal Stromal Tumor Recurrence After Resection.医生低估胃肠道间质瘤切除术后复发风险。
JAMA Oncol. 2015 Sep;1(6):797-805. doi: 10.1001/jamaoncol.2015.2407.
7
Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis.早幼粒细胞白血病在胃肠道间质瘤中的表达的预后意义;蛋白质组学和转录组学综合分析
Cancer Sci. 2015 Jan;106(1):115-24. doi: 10.1111/cas.12565. Epub 2014 Dec 4.
8
Expression and clinicopathological significance of CD9 in gastrointestinal stromal tumor.CD9 在胃肠道间质瘤中的表达及临床病理意义。
J Korean Med Sci. 2013 Oct;28(10):1443-8. doi: 10.3346/jkms.2013.28.10.1443. Epub 2013 Sep 25.
9
Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor.术前血小板与淋巴细胞比值升高预示原发性胃肠道间质瘤患者预后不良。
BMC Gastroenterol. 2020 Apr 22;20(1):124. doi: 10.1186/s12876-020-01275-2.
10
Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.鉴定载脂蛋白受体 A 类结构域包含蛋白 4(LDLRAD4)作为原发性胃肠间质瘤的预后指标。
Curr Probl Cancer. 2020 Dec;44(6):100593. doi: 10.1016/j.currproblcancer.2020.100593. Epub 2020 May 27.

引用本文的文献

1
Advancement in medical treatment for gastrointestinal stromal tumors (GISTs): a ray of hope.胃肠道间质瘤(GISTs)医学治疗的进展:一线希望。
Ann Med Surg (Lond). 2024 Dec 19;87(3):1383-1393. doi: 10.1097/MS9.0000000000002843. eCollection 2025 Mar.

本文引用的文献

1
SOCS6 promotes radiosensitivity and decreases cancer cell stemness in esophageal squamous cell carcinoma by regulating c-Kit ubiquitylation.信号转导和转录激活因子6(SOCS6)通过调节c-Kit泛素化促进食管鳞状细胞癌的放射敏感性并降低癌细胞干性。
Cancer Cell Int. 2021 Mar 12;21(1):165. doi: 10.1186/s12935-021-01859-2.
2
High expression of proenkephalin is associated with favorable outcomes in patients with gastrointestinal stromal tumors.前脑啡肽原的高表达与胃肠道间质瘤患者的良好预后相关。
Cancer Manag Res. 2019 Jul 17;11:6681-6690. doi: 10.2147/CMAR.S202044. eCollection 2019.
3
Targeted therapy and personalized medicine in gastrointestinal stromal tumors: drug resistance, mechanisms, and treatment strategies.
胃肠道间质瘤的靶向治疗与个性化医疗:耐药性、机制及治疗策略
Onco Targets Ther. 2019 Jul 1;12:5123-5133. doi: 10.2147/OTT.S180763. eCollection 2019.
4
kshv-mir-k12-1-5p promotes cell growth and metastasis by targeting SOCS6 in Kaposi's sarcoma cells.卡波西肉瘤病毒微小RNA - K12 - 1 - 5p通过靶向信号转导子与转录激活子6(SOCS6)促进卡波西肉瘤细胞的生长和转移。
Cancer Manag Res. 2019 May 29;11:4985-4995. doi: 10.2147/CMAR.S198411. eCollection 2019.
5
miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC.miR-1260b 通过 YY1 介导,通过靶向 SOCS6 激活 KIT 信号通路,调节 NSCLC 中的细胞增殖和凋亡。
Cell Death Dis. 2019 Feb 8;10(2):112. doi: 10.1038/s41419-019-1390-y.
6
Long noncoding RNA neuroblastoma-associated transcript 1 gene inhibits malignant cellular phenotypes of bladder cancer through miR-21/SOCS6 axis.长链非编码 RNA 神经母细胞瘤相关转录本 1 基因通过 miR-21/SOCS6 轴抑制膀胱癌的恶性细胞表型。
Cell Death Dis. 2018 Oct 11;9(10):1042. doi: 10.1038/s41419-018-1090-z.
7
Interference with NTSR1 Expression Exerts an Anti-Invasion Effect via the Jun/miR-494/SOCS6 Axis of Glioblastoma Cells.干扰NTSR1表达通过胶质母细胞瘤细胞的Jun/miR-494/SOCS6轴发挥抗侵袭作用。
Cell Physiol Biochem. 2018;49(6):2382-2395. doi: 10.1159/000493838. Epub 2018 Sep 27.
8
Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance.携带伊马替尼耐药的胃肠道间质瘤的全基因组 CRISPR-Cas9 敲除筛选
Mol Cancer. 2018 Aug 13;17(1):121. doi: 10.1186/s12943-018-0865-2.
9
SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer.SOCS6 通过诱导细胞凋亡和抑制血管生成在人前列腺癌中发挥肿瘤抑制作用。
Curr Cancer Drug Targets. 2018;18(9):894-904. doi: 10.2174/1568009618666180102101442.
10
Gastrointestinal Stromal Tumors.胃肠道间质瘤。
J Clin Oncol. 2018 Jan 10;36(2):136-143. doi: 10.1200/JCO.2017.74.9705. Epub 2017 Dec 8.